Dr. Redeschi joined BI – Miami as a Drug Safety Evaluator in 2015 and was promoted to Coordinator, South American Division in 2018. Prior to joining BI, she was in retail pharmacy with CVS for ten years. She graduated from UMC Pharmacy School in São Paulo, Brazil in 2000, and became a registered pharmacist in the United States in 2009. In 2012, she received her Consulting Pharmacist license and, in early 2018, she became certified in Brazilian Regulatory Affairs. In April 2019, Ms. Redeschi was a speaker at the OTC Seminar promoted by Anvisa and ABMIP and in October of that year she was a speaker at the Naming Development Seminar promoted by Anvisa and Sindusfarma. Dr. Redeschi has led the regulatory and safety research efforts for dozens of Brazilian and Latin American projects, highlighted by ANVISA approvals that include GSK’s Trelegy, EMS’ Bexai and Seqirus’ Flucelvax.